5-aminopyrazole-4-carboxamide inhibitors of CDPK1 from T. gondii and C. parvum

摘要

The present disclosure is generally directed to compositions and methods for treating apicomplexan protozoan related disease, such as toxoplasmosis and cryptosporidiosis.